• 9964432222
  • Mail Us
  • Appointment
  • Locate Us
  • Chat Now
  • Courses
  • Login
  • Register
Manifest IAS
JournalsOfIndia
Manifest Learning Academy
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
  • Home
  • SNIPPETSfor Prelims
  • ARTICLESfor Mains
  • BROWSEBY SOURCE
  • DOWNLOADS
No Result
View All Result
JournalsOfIndia
No Result
View All Result
Home Science & Tech

Paxlovid

December 24, 2021
in Science & Tech
Reading Time: 1 min read
0
Paxlovid
146
VIEWS
Share on WhatsAppShare on TelegramShare on Facebook
image_pdfMake PDF

In news- Recently, US Pharma Giant Pfizer has received USFDA emergency use authorization for its Covid-19 antiviral treatment Paxlovid.

About Paxlovid-

  • It is an antiviral Covid-19 treatment candidate, PF-07321332, which is administered in combination with low dose HIV medicine ritonavir.
  • It showed a reduced risk of hospitalisation or death by 89 per cent, within three days of symptom onset; and 88 per cent, within five days of symptom onset, as compared to the placebo group.
  • Paxlovid can be used to treat adults with Covid-19 who do not require supplemental oxygen and who are at increased risk of progressing to severe disease.
  • Pfizer announced a deal with the United Nations backed public health organization Medicines Patent Pool (MPP). 
  • Under the deal, it signed a voluntary license agreement for Covid-19 oral antiviral treatment candidate Paxlovid. 
  • The agreement will facilitate the production and distribution of Paxlovid by granting sub-licenses to qualified generic medicine manufacturers.
  • The drug, Paxlovid, is a faster way to treat early COVID-19 infections, though initial supplies will be extremely limited. 
  • All of the previously authorized drugs against the disease require an IV or an injection.
image_pdfMake PDF
Source: The Indian Express
Tags: News PaperPrelims

Related Posts

Visible Emission Line Coronograph(VELC) for India’s first solar mission

Visible Emission Line Coronograph(VELC) for India’s first solar mission

January 27, 2023
Padma awards in the field of Medicine

Padma awards in the field of Medicine

January 27, 2023
Idea Train Profile

Idea Train Profile

January 26, 2023
New surgical knife can detect endometrial cancer within seconds

New surgical knife can detect endometrial cancer within seconds

January 25, 2023
Immune imprinting

Immune imprinting

January 23, 2023
BharOS

BharOS

January 23, 2023
Hybrid immunity

Hybrid immunity

January 21, 2023
Pantranscriptome

Pantranscriptome

January 21, 2023
Superconductivity of mercury

Superconductivity of mercury

January 21, 2023
Shadow banning of social media posts

Shadow banning of social media posts

January 20, 2023
Please login to join discussion
JournalsOfIndia

Our vision is to orient the readers to grasp the facts objectively and analyse critically. In the rush of reaching first to the readers, the websites miss the balanced opinion, which is the need of the hour. We aim to reach the readers with more crispness, preciseness and relevance. We bring the articles in UPSC way for the civil services aspirants and the Wisest Way for general readers.

Categories

  • Agriculture
  • Disaster Management
  • Economy
  • Environment
  • Ethics
  • Foreign Affairs
  • Geography
  • Governance
  • History
  • Law & Policy
  • Opinion
  • People in News
  • Places in News
  • Science & Tech
  • Security
  • Society
  • Sports
  • Uncategorized

Browse by Tag

AIR All India Radio BBC Business Line Business Standard dow Down to Earth DownToEarth DTE Economic Times ET FAO Financial Express GS-1 GS-2 GS-3 GS-4 Hindustan Times IE India & the world Indian express Indiatoday India today Kurukshetra Livelihoods portal LiveMint Mains News News Paper Newspaper PIB Prelims PRS India RSTV Science Reporter Survey The Hindu The India Express The Indian Express The Print the wire Times of India TOI TOPPERS Yojana

Newsletter

The most important UPSC news and events of the day.

Get Journals daily newsletter on your inbox.

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

  • Login
  • Sign Up
  • Home
  • SNIPPETS
  • ARTICLES
  • BROWSE
  • DOWNLOADS
No Result
View All Result

© 2020 JournalsOfIndia - A free initiative by Manifest Team.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In